UASt regulatory sequences drive expression of an inverted repeat.
Expression of auxKK100927 (together with UAS-Dicer2 to enhance RNAi efficiency) under the control of either Scer\GAL4ple.PU or Scer\GAL4Ddc.PU leads to age-progressive decline of the adult locomotor (climbing) abilities. Scer\GAL4ple.PU-driven expression also results in age-dependent loss of dopaminergic neurons from the PPM1/2 in the brain of aged (33 days old) but not young (3 days old) adult flies. Expression driven by the Scer\GAL4GMR58E02 driver has no evident effect on the number of dopaminergic neurons from the PAM cluster regardless of age.
auxKK100927, Scer\GAL4Ddc.PU is an enhancer of abnormal neuroanatomy | adult stage phenotype of Hsap\SNCAA30P.UAS.cUa, Scer\GAL4Ddc.PU
auxKK100927, Scer\GAL4Ddc.PU is an enhancer of decreased cell number | adult stage phenotype of Hsap\SNCAA30P.UAS.cUa, Scer\GAL4Ddc.PU
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU, auxKK100927 has abnormal neuroanatomy | adult stage phenotype
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU, auxKK100927 has decreased cell number | adult stage phenotype
Hsap\SNCAA30P.UAS.cUa, Scer\GAL4ple.PU, auxKK100927 has abnormal neuroanatomy | adult stage phenotype
Hsap\SNCAA30P.UAS.cUa, Scer\GAL4ple.PU, auxKK100927 has decreased cell number | adult stage phenotype
auxKK100927, Scer\GAL4Ddc.PU is an enhancer of dopaminergic PPM1 neuron | adult stage phenotype of Hsap\SNCAA30P.UAS.cUa, Scer\GAL4Ddc.PU
auxKK100927, Scer\GAL4Ddc.PU is an enhancer of dopaminergic PPM2 neuron | adult stage phenotype of Hsap\SNCAA30P.UAS.cUa, Scer\GAL4Ddc.PU
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU, auxKK100927 has dopaminergic PPM2 neuron | adult stage phenotype
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU, auxKK100927 has dopaminergic PPM1 neuron | adult stage phenotype
Hsap\SNCAA30P.UAS.cUa, Scer\GAL4ple.PU, auxKK100927 has dopaminergic PPM2 neuron | adult stage phenotype
The loss of dopaminergic PPM1/2 neurons observed even in very young adult flies expressing Hsap\SNCAA30P.Scer\UAS.cUa under the control of Scer\GAL4Ddc.PU is exacerbated further by co-expression of auxKK100927 RNAi and the number of neurons is further decreased. Simultaneous expression of the two transgenes driven by Scer\GAL4ple.PU also leads to early-onset loss of PPM1/2, which is otherwise not observed in young (3 or 10 days old) flies expressing either of the transgenes alone with this driver.
auxKK100927 is rescued by Scer\GAL4ple.PU/auxFL.UAS.GFP
auxKK100927 is rescued by Scer\GAL4Ddc.PU/auxFL.UAS.GFP
The age-progressive rapid deterioration in adult locomotion (climbing ability) characteristic for flies expressing auxKK100927 (together with UAS-Dicer2 to enhance RNAi efficiency) under the control of either Scer\GAL4ple.PU or Scer\GAL4Ddc.PU can be rescued by co-expression of auxFL.Scer\UAS.T:Avic\GFP.
Co-expression of Hsap\SNCAScer\UAS.cUa (but not Hsap\SNCAA53T.Scer\UAS.cUa) with auxKK100927 leads to significant decrease in the number of dopaminergic PPM1/2 neurons in the brains of young (3 and/or 10 days old) adult flies, which is not observed at this age when any of the transgenes is expressed alone.